

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.83337649 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.83337649 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.56137766 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.56137766 |
| 5 | valine metabolic process (GO:0006573) | 4.32206677 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.25578050 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.09612448 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.09612448 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.04100121 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.04100121 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.04100121 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.04100121 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.04100121 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.04100121 |
| 15 | mannose metabolic process (GO:0006013) | 4.01370382 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93199852 |
| 17 | detection of bacterium (GO:0016045) | 3.88287621 |
| 18 | detection of other organism (GO:0098543) | 3.87080132 |
| 19 | response to peptidoglycan (GO:0032494) | 3.85388567 |
| 20 | leukocyte aggregation (GO:0070486) | 3.81343413 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.78493739 |
| 22 | L-phenylalanine catabolic process (GO:0006559) | 3.78493739 |
| 23 | tricarboxylic acid metabolic process (GO:0072350) | 3.77386994 |
| 24 | lysine catabolic process (GO:0006554) | 3.70012234 |
| 25 | lysine metabolic process (GO:0006553) | 3.70012234 |
| 26 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.66328804 |
| 27 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.63599771 |
| 28 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53575682 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.47470567 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.41840886 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.39385472 |
| 32 | glyoxylate metabolic process (GO:0046487) | 3.37147495 |
| 33 | ribosomal small subunit assembly (GO:0000028) | 3.32191524 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.25810788 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.18920518 |
| 36 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.16136963 |
| 37 | aromatic amino acid family catabolic process (GO:0009074) | 3.15071485 |
| 38 | fatty acid beta-oxidation (GO:0006635) | 3.14864453 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 3.13874969 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.13836256 |
| 41 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.12077513 |
| 42 | protein carboxylation (GO:0018214) | 3.12077513 |
| 43 | oxaloacetate metabolic process (GO:0006107) | 3.09371011 |
| 44 | germinal center formation (GO:0002467) | 3.08797333 |
| 45 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08070276 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06148241 |
| 47 | thymic T cell selection (GO:0045061) | 3.04643366 |
| 48 | cysteine metabolic process (GO:0006534) | 3.03714004 |
| 49 | kynurenine metabolic process (GO:0070189) | 3.02354590 |
| 50 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02094074 |
| 51 | sulfur amino acid catabolic process (GO:0000098) | 3.00105327 |
| 52 | regulation of cholesterol homeostasis (GO:2000188) | 2.96732726 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 2.91876380 |
| 54 | regulation of triglyceride catabolic process (GO:0010896) | 2.90115651 |
| 55 | Golgi transport vesicle coating (GO:0048200) | 2.89631560 |
| 56 | COPI coating of Golgi vesicle (GO:0048205) | 2.89631560 |
| 57 | ethanol oxidation (GO:0006069) | 2.88624389 |
| 58 | glycine metabolic process (GO:0006544) | 2.88600195 |
| 59 | 4-hydroxyproline metabolic process (GO:0019471) | 2.88549368 |
| 60 | fatty acid oxidation (GO:0019395) | 2.87955380 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.84408136 |
| 62 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.83992772 |
| 63 | response to laminar fluid shear stress (GO:0034616) | 2.83352137 |
| 64 | viral transcription (GO:0019083) | 2.83192282 |
| 65 | lipid oxidation (GO:0034440) | 2.80686000 |
| 66 | detection of biotic stimulus (GO:0009595) | 2.79373162 |
| 67 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.79206526 |
| 68 | regulation of leukocyte degranulation (GO:0043300) | 2.78425003 |
| 69 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.77601412 |
| 70 | fatty acid catabolic process (GO:0009062) | 2.77495526 |
| 71 | regulation of ARF GTPase activity (GO:0032312) | 2.77137687 |
| 72 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.76235160 |
| 73 | negative regulation of granulocyte differentiation (GO:0030853) | 2.76215338 |
| 74 | regulation of extracellular matrix disassembly (GO:0010715) | 2.74425531 |
| 75 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.73911709 |
| 76 | negative regulation of interleukin-12 production (GO:0032695) | 2.73548081 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.72556894 |
| 78 | T cell selection (GO:0045058) | 2.71881272 |
| 79 | regulation of gamma-delta T cell activation (GO:0046643) | 2.71586182 |
| 80 | carnitine metabolic process (GO:0009437) | 2.70453077 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.70350303 |
| 82 | negative regulation of fibrinolysis (GO:0051918) | 2.70240499 |
| 83 | positive regulation of histone deacetylation (GO:0031065) | 2.70045994 |
| 84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.69247019 |
| 85 | tryptophan catabolic process (GO:0006569) | 2.69074814 |
| 86 | indole-containing compound catabolic process (GO:0042436) | 2.69074814 |
| 87 | indolalkylamine catabolic process (GO:0046218) | 2.69074814 |
| 88 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68565630 |
| 89 | response to host (GO:0075136) | 2.68565630 |
| 90 | response to host defenses (GO:0052200) | 2.68565630 |
| 91 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.68514624 |
| 92 | branched-chain amino acid metabolic process (GO:0009081) | 2.67393796 |
| 93 | translational termination (GO:0006415) | 2.66407419 |
| 94 | complement activation, alternative pathway (GO:0006957) | 2.66005941 |
| 95 | regulation of mast cell degranulation (GO:0043304) | 2.65807642 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.65682497 |
| 97 | response to host immune response (GO:0052572) | 2.65682497 |
| 98 | modulation by virus of host process (GO:0019054) | 2.65301199 |
| 99 | NIK/NF-kappaB signaling (GO:0038061) | 2.65159198 |
| 100 | tryptophan metabolic process (GO:0006568) | 2.65044760 |
| 101 | modulation by symbiont of host cellular process (GO:0044068) | 2.63141334 |
| 102 | pentose-phosphate shunt (GO:0006098) | 2.61876328 |
| 103 | plasma lipoprotein particle clearance (GO:0034381) | 2.61792599 |
| 104 | detection of molecule of bacterial origin (GO:0032490) | 2.61762692 |
| 105 | protein targeting to ER (GO:0045047) | 2.61358260 |
| 106 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.61148786 |
| 107 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.60424815 |
| 108 | homocysteine metabolic process (GO:0050667) | 2.59399316 |
| 109 | urea cycle (GO:0000050) | 2.58781285 |
| 110 | urea metabolic process (GO:0019627) | 2.58781285 |
| 111 | tolerance induction (GO:0002507) | 2.58714937 |
| 112 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.58383923 |
| 113 | serine family amino acid catabolic process (GO:0009071) | 2.58301835 |
| 114 | drug transmembrane transport (GO:0006855) | 2.58155816 |
| 115 | maternal placenta development (GO:0001893) | 2.57771769 |
| 116 | response to type I interferon (GO:0034340) | 2.57710735 |
| 117 | positive thymic T cell selection (GO:0045059) | 2.57662057 |
| 118 | negative regulation of cell size (GO:0045792) | 2.57080840 |
| 119 | cellular extravasation (GO:0045123) | 2.56544138 |
| 120 | bile acid biosynthetic process (GO:0006699) | 2.56507354 |
| 121 | cotranslational protein targeting to membrane (GO:0006613) | 2.56400160 |
| 122 | negative regulation of innate immune response (GO:0045824) | 2.55188703 |
| 123 | fatty acid transmembrane transport (GO:1902001) | 2.54613120 |
| 124 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.54507339 |
| 125 | short-chain fatty acid metabolic process (GO:0046459) | 2.53825178 |
| 126 | macrophage activation (GO:0042116) | 2.53809808 |
| 127 | cellular response to type I interferon (GO:0071357) | 2.53793501 |
| 128 | type I interferon signaling pathway (GO:0060337) | 2.53793501 |
| 129 | immunoglobulin mediated immune response (GO:0016064) | 2.53019738 |
| 130 | monocarboxylic acid catabolic process (GO:0072329) | 2.51797229 |
| 131 | aspartate family amino acid catabolic process (GO:0009068) | 2.51641961 |
| 132 | negative regulation of cholesterol transport (GO:0032375) | 2.51332946 |
| 133 | negative regulation of sterol transport (GO:0032372) | 2.51332946 |
| 134 | positive regulation of protein deacetylation (GO:0090312) | 2.51200180 |
| 135 | respiratory burst (GO:0045730) | 2.50566765 |
| 136 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.50380568 |
| 137 | acylglycerol homeostasis (GO:0055090) | 2.50310063 |
| 138 | triglyceride homeostasis (GO:0070328) | 2.50310063 |
| 139 | serine family amino acid metabolic process (GO:0009069) | 2.49379254 |
| 140 | low-density lipoprotein particle clearance (GO:0034383) | 2.47850648 |
| 141 | phospholipid efflux (GO:0033700) | 2.47808542 |
| 142 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.46426896 |
| 143 | regulation of protein activation cascade (GO:2000257) | 2.45010037 |
| 144 | protein localization to endoplasmic reticulum (GO:0070972) | 2.44371928 |
| 145 | acetyl-CoA metabolic process (GO:0006084) | 2.44354623 |
| 146 | translational elongation (GO:0006414) | 2.44353826 |
| 147 | regulation of fatty acid oxidation (GO:0046320) | 2.43608375 |
| 148 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.43102308 |
| 149 | cellular modified amino acid catabolic process (GO:0042219) | 2.43050814 |
| 150 | serine family amino acid biosynthetic process (GO:0009070) | 2.41781643 |
| 151 | neutrophil activation (GO:0042119) | 2.41339709 |
| 152 | high-density lipoprotein particle remodeling (GO:0034375) | 2.40930931 |
| 153 | semaphorin-plexin signaling pathway (GO:0071526) | 2.40910762 |
| 154 | barbed-end actin filament capping (GO:0051016) | 2.40718565 |
| 155 | regulation of cholesterol storage (GO:0010885) | 2.40485340 |
| 156 | negative regulation of type 2 immune response (GO:0002829) | 2.39957223 |
| 157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.39617816 |
| 158 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.39291480 |
| 159 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.39250844 |
| 160 | regulation of regulated secretory pathway (GO:1903305) | 2.39189753 |
| 161 | negative regulation of interleukin-6 production (GO:0032715) | 2.39081918 |
| 162 | nitrogen cycle metabolic process (GO:0071941) | 2.38497717 |
| 163 | regulation of cholesterol metabolic process (GO:0090181) | 2.37004280 |
| 164 | regulation of triglyceride metabolic process (GO:0090207) | 2.36969327 |
| 165 | carnitine shuttle (GO:0006853) | 2.36900622 |
| 166 | cellular response to virus (GO:0098586) | 2.36185457 |
| 167 | apoptotic process involved in morphogenesis (GO:0060561) | 2.35892674 |
| 168 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.35828826 |
| 169 | signal complex assembly (GO:0007172) | 2.35464740 |
| 170 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.35171583 |
| 171 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.34545398 |
| 172 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.34265686 |
| 173 | alpha-amino acid catabolic process (GO:1901606) | 2.34105779 |
| 174 | regulation of fibrinolysis (GO:0051917) | 2.33779001 |
| 175 | purine nucleotide salvage (GO:0032261) | 2.33646915 |
| 176 | regulation of complement activation (GO:0030449) | 2.33023209 |
| 177 | cell-substrate adherens junction assembly (GO:0007045) | 2.32696994 |
| 178 | focal adhesion assembly (GO:0048041) | 2.32696994 |
| 179 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.32349808 |
| 180 | actin filament polymerization (GO:0030041) | 2.32099787 |
| 181 | regulation of ARF protein signal transduction (GO:0032012) | 2.31997526 |
| 182 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.31549937 |
| 183 | stress fiber assembly (GO:0043149) | 2.31185353 |
| 184 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.29723483 |
| 185 | regulation of lipid kinase activity (GO:0043550) | 2.29564763 |
| 186 | granulocyte activation (GO:0036230) | 2.29283364 |
| 187 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.29036932 |
| 188 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.27598913 |
| 189 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.26976942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.88911324 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.88824443 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.46619371 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.31855579 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.73337546 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.57732820 |
| 7 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.47951395 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.42545510 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.30059516 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.25693171 |
| 11 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.22318687 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19713738 |
| 13 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.14130844 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.03435144 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.00513897 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.98471860 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.88034511 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86385447 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.85945647 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84713827 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81159502 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80017818 |
| 23 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.79880709 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.78750044 |
| 25 | KDM2B_26808549_Chip-Seq_K562_Human | 1.78707230 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76896734 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74666842 |
| 28 | P68_20966046_ChIP-Seq_HELA_Human | 1.74227230 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.70000383 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66439089 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.65746016 |
| 32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64010021 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.63052366 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60886972 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60423993 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59965920 |
| 37 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.59285478 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.58354560 |
| 39 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.57935410 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57634208 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57604537 |
| 42 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.56515948 |
| 43 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.55996615 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55968333 |
| 45 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.55826860 |
| 46 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.55491816 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.55038375 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54993896 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54322182 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52785281 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52101307 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50535749 |
| 53 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49882338 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48529534 |
| 55 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46462294 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.45359758 |
| 57 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.44982175 |
| 58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.43984655 |
| 59 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.43414446 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42951766 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41325057 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39474672 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39050062 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39041508 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.38437577 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38239703 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.36602471 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35255381 |
| 69 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33438751 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32937709 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32686253 |
| 72 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.32530891 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31621543 |
| 74 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.28532166 |
| 75 | MYB_26560356_Chip-Seq_TH1_Human | 1.28176967 |
| 76 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.27366792 |
| 77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27087722 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26800655 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26760972 |
| 80 | MYB_26560356_Chip-Seq_TH2_Human | 1.26514146 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24727144 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24575850 |
| 83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23912412 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23756253 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21666833 |
| 86 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21608184 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21367050 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20313588 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20289535 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.19764832 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19726342 |
| 92 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19295095 |
| 93 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18542711 |
| 94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18456374 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18432472 |
| 96 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18326649 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17868006 |
| 98 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17831745 |
| 99 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16665006 |
| 100 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.16529821 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16273986 |
| 102 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15566994 |
| 103 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15330371 |
| 104 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14887667 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14257315 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13583270 |
| 107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13431565 |
| 108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.13355956 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12602542 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11236589 |
| 111 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10758164 |
| 112 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.10283838 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10117110 |
| 114 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.09944194 |
| 115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09297369 |
| 116 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08118222 |
| 117 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06566015 |
| 118 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.06451179 |
| 119 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06412471 |
| 120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06276350 |
| 121 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.04833812 |
| 122 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03741836 |
| 123 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03218161 |
| 124 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02804083 |
| 125 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02789443 |
| 126 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.02675691 |
| 127 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02086976 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01347475 |
| 129 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00940074 |
| 130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00869965 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98739943 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98388071 |
| 133 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97696183 |
| 134 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96308467 |
| 135 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.95935127 |
| 136 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95557524 |
| 137 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95440416 |
| 138 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94289974 |
| 139 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.93298714 |
| 140 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.91563982 |
| 141 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90395119 |
| 142 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.88878505 |
| 143 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88110886 |
| 144 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87948776 |
| 145 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.87362782 |
| 146 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86700452 |
| 147 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86623369 |
| 148 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86398422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.71189494 |
| 2 | MP0005360_urolithiasis | 3.33904711 |
| 3 | MP0005365_abnormal_bile_salt | 2.95067715 |
| 4 | MP0003172_abnormal_lysosome_physiology | 2.80660022 |
| 5 | MP0008260_abnormal_autophagy | 2.79263571 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.63398883 |
| 7 | MP0005451_abnormal_body_composition | 2.57823773 |
| 8 | MP0009840_abnormal_foam_cell | 2.46866378 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.13795815 |
| 10 | MP0003252_abnormal_bile_duct | 2.09161130 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.05918998 |
| 12 | MP0004510_myositis | 2.05029732 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.00643931 |
| 14 | MP0004381_abnormal_hair_follicle | 1.98389363 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 1.85259627 |
| 16 | MP0005076_abnormal_cell_differentiation | 1.83129143 |
| 17 | MP0005083_abnormal_biliary_tract | 1.82807606 |
| 18 | MP0000685_abnormal_immune_system | 1.82627904 |
| 19 | MP0010329_abnormal_lipoprotein_level | 1.79161858 |
| 20 | MP0001849_ear_inflammation | 1.77757931 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.70496523 |
| 22 | MP0003195_calcinosis | 1.65378024 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.64832991 |
| 24 | MP0001835_abnormal_antigen_presentation | 1.61593389 |
| 25 | MP0001666_abnormal_nutrient_absorption | 1.59657961 |
| 26 | MP0000609_abnormal_liver_physiology | 1.57742869 |
| 27 | MP0002877_abnormal_melanocyte_morpholog | 1.57445208 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.57000850 |
| 29 | MP0006082_CNS_inflammation | 1.56372244 |
| 30 | MP0003828_pulmonary_edema | 1.55786489 |
| 31 | MP0003436_decreased_susceptibility_to | 1.54910660 |
| 32 | MP0004858_abnormal_nervous_system | 1.53747515 |
| 33 | MP0000751_myopathy | 1.52673511 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.51563148 |
| 35 | MP0005332_abnormal_amino_acid | 1.45942406 |
| 36 | MP0002998_abnormal_bone_remodeling | 1.44236080 |
| 37 | MP0002132_abnormal_respiratory_system | 1.43921884 |
| 38 | MP0000858_altered_metastatic_potential | 1.41890997 |
| 39 | MP0005670_abnormal_white_adipose | 1.41854463 |
| 40 | MP0003724_increased_susceptibility_to | 1.41572995 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.38262677 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.37161516 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.35703853 |
| 44 | MP0004130_abnormal_muscle_cell | 1.33951495 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.32613593 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.32479580 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.31869162 |
| 48 | MP0005387_immune_system_phenotype | 1.27959412 |
| 49 | MP0001790_abnormal_immune_system | 1.27959412 |
| 50 | MP0003303_peritoneal_inflammation | 1.27433182 |
| 51 | MP0003279_aneurysm | 1.26586846 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.26443526 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.25398743 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.25094315 |
| 55 | MP0003183_abnormal_peptide_metabolism | 1.24513588 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.24362727 |
| 57 | MP0001958_emphysema | 1.24147687 |
| 58 | MP0004185_abnormal_adipocyte_glucose | 1.23662820 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 1.22031640 |
| 60 | MP0006054_spinal_hemorrhage | 1.21374511 |
| 61 | MP0003075_altered_response_to | 1.19328925 |
| 62 | MP0001853_heart_inflammation | 1.19068315 |
| 63 | MP0005025_abnormal_response_to | 1.18450978 |
| 64 | MP0001800_abnormal_humoral_immune | 1.18133107 |
| 65 | MP0005409_darkened_coat_color | 1.17892052 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.17849322 |
| 67 | MP0008469_abnormal_protein_level | 1.14876211 |
| 68 | MP0002249_abnormal_larynx_morphology | 1.14455049 |
| 69 | MP0005220_abnormal_exocrine_pancreas | 1.11232353 |
| 70 | MP0000598_abnormal_liver_morphology | 1.09823638 |
| 71 | MP0004084_abnormal_cardiac_muscle | 1.09349509 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.08841179 |
| 73 | MP0009785_altered_susceptibility_to | 1.08399072 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.08041839 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.07151155 |
| 76 | MP0000747_muscle_weakness | 1.05907498 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05347331 |
| 78 | MP0005390_skeleton_phenotype | 1.04468204 |
| 79 | MP0000678_abnormal_parathyroid_gland | 1.03527429 |
| 80 | MP0003690_abnormal_glial_cell | 1.03022766 |
| 81 | MP0005000_abnormal_immune_tolerance | 1.02316067 |
| 82 | MP0000749_muscle_degeneration | 1.01997044 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.01943780 |
| 84 | MP0002796_impaired_skin_barrier | 1.01399677 |
| 85 | MP0001545_abnormal_hematopoietic_system | 1.01289338 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 1.01289338 |
| 87 | MP0003186_abnormal_redox_activity | 1.00883127 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 1.00826281 |
| 89 | MP0003091_abnormal_cell_migration | 1.00483104 |
| 90 | MP0005330_cardiomyopathy | 1.00464493 |
| 91 | MP0005671_abnormal_response_to | 1.00418150 |
| 92 | MP0003329_amyloid_beta_deposits | 0.99708874 |
| 93 | MP0002723_abnormal_immune_serum | 0.99509922 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.98856037 |
| 95 | MP0002452_abnormal_antigen_presenting | 0.98701124 |
| 96 | MP0001851_eye_inflammation | 0.98596029 |
| 97 | MP0002419_abnormal_innate_immunity | 0.98578729 |
| 98 | MP0004947_skin_inflammation | 0.96259273 |
| 99 | MP0009278_abnormal_bone_marrow | 0.96221537 |
| 100 | MP0004036_abnormal_muscle_relaxation | 0.95985348 |
| 101 | MP0001873_stomach_inflammation | 0.95294704 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.93843013 |
| 103 | MP0003646_muscle_fatigue | 0.93673382 |
| 104 | MP0002398_abnormal_bone_marrow | 0.92842320 |
| 105 | MP0002405_respiratory_system_inflammati | 0.92646540 |
| 106 | MP0000689_abnormal_spleen_morphology | 0.92368507 |
| 107 | MP0002420_abnormal_adaptive_immunity | 0.91748288 |
| 108 | MP0003866_abnormal_defecation | 0.91598954 |
| 109 | MP0004808_abnormal_hematopoietic_stem | 0.91582748 |
| 110 | MP0000465_gastrointestinal_hemorrhage | 0.91063644 |
| 111 | MP0008874_decreased_physiological_sensi | 0.90757100 |
| 112 | MP0001819_abnormal_immune_cell | 0.90502614 |
| 113 | MP0000604_amyloidosis | 0.90031085 |
| 114 | MP0000703_abnormal_thymus_morphology | 0.89732589 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.89001090 |
| 116 | MP0004264_abnormal_extraembryonic_tissu | 0.88954836 |
| 117 | MP0009763_increased_sensitivity_to | 0.88442346 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.88329463 |
| 119 | MP0002933_joint_inflammation | 0.88304875 |
| 120 | MP0008961_abnormal_basal_metabolism | 0.88125164 |
| 121 | MP0004087_abnormal_muscle_fiber | 0.87075156 |
| 122 | MP0002722_abnormal_immune_system | 0.87000821 |
| 123 | MP0003656_abnormal_erythrocyte_physiolo | 0.86687009 |
| 124 | MP0010630_abnormal_cardiac_muscle | 0.86374323 |
| 125 | MP0001879_abnormal_lymphatic_vessel | 0.86140501 |
| 126 | MP0000003_abnormal_adipose_tissue | 0.85970694 |
| 127 | MP0000750_abnormal_muscle_regeneration | 0.85584048 |
| 128 | MP0000716_abnormal_immune_system | 0.85328267 |
| 129 | MP0000767_abnormal_smooth_muscle | 0.85030942 |
| 130 | MP0005636_abnormal_mineral_homeostasis | 0.84774670 |
| 131 | MP0001944_abnormal_pancreas_morphology | 0.84245957 |
| 132 | MP0004883_abnormal_blood_vessel | 0.83925723 |
| 133 | MP0005377_hearing/vestibular/ear_phenot | 0.83315162 |
| 134 | MP0003878_abnormal_ear_physiology | 0.83315162 |
| 135 | MP0001533_abnormal_skeleton_physiology | 0.83166333 |
| 136 | MP0003868_abnormal_feces_composition | 0.82647582 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.82429886 |
| 138 | MP0002429_abnormal_blood_cell | 0.81860577 |
| 139 | MP0000249_abnormal_blood_vessel | 0.81734505 |
| 140 | MP0002136_abnormal_kidney_physiology | 0.81541702 |
| 141 | MP0000759_abnormal_skeletal_muscle | 0.81053563 |
| 142 | MP0004019_abnormal_vitamin_homeostasis | 0.81034859 |
| 143 | MP0003879_abnormal_hair_cell | 0.80775264 |
| 144 | MP0001348_abnormal_lacrimal_gland | 0.80746114 |
| 145 | MP0005166_decreased_susceptibility_to | 0.79377974 |
| 146 | MP0005310_abnormal_salivary_gland | 0.78968764 |
| 147 | MP0003123_paternal_imprinting | 0.78198689 |
| 148 | MP0001663_abnormal_digestive_system | 0.76975935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.49497075 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.08255284 |
| 3 | Recurrent abscess formation (HP:0002722) | 3.64790675 |
| 4 | Xanthomatosis (HP:0000991) | 3.50969324 |
| 5 | Abnormality of macrophages (HP:0004311) | 3.43637261 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.42075995 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.40524726 |
| 8 | Ketosis (HP:0001946) | 3.28969158 |
| 9 | Myositis (HP:0100614) | 3.25353223 |
| 10 | Ketoacidosis (HP:0001993) | 3.16895297 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 3.16426495 |
| 12 | Hypoglycemic seizures (HP:0002173) | 3.16226484 |
| 13 | Distal lower limb muscle weakness (HP:0009053) | 3.12494295 |
| 14 | Late onset (HP:0003584) | 3.10872892 |
| 15 | J-shaped sella turcica (HP:0002680) | 3.09641714 |
| 16 | Generalized aminoaciduria (HP:0002909) | 3.07854451 |
| 17 | Myoglobinuria (HP:0002913) | 3.04998050 |
| 18 | Obstructive sleep apnea (HP:0002870) | 3.03264783 |
| 19 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.99657579 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.95622386 |
| 21 | Cerebral aneurysm (HP:0004944) | 2.91461421 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.91205667 |
| 23 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.89363957 |
| 24 | Hyperammonemia (HP:0001987) | 2.80256537 |
| 25 | Orchitis (HP:0100796) | 2.79749697 |
| 26 | Increased IgE level (HP:0003212) | 2.77044934 |
| 27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.76457588 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 2.73601187 |
| 29 | Broad face (HP:0000283) | 2.70073932 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 2.68926873 |
| 31 | Obstructive lung disease (HP:0006536) | 2.65054823 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65054823 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 2.64196553 |
| 34 | Thin bony cortex (HP:0002753) | 2.64155433 |
| 35 | Thrombocytosis (HP:0001894) | 2.62005215 |
| 36 | Dicarboxylic aciduria (HP:0003215) | 2.54616630 |
| 37 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54616630 |
| 38 | Joint hemorrhage (HP:0005261) | 2.51114590 |
| 39 | Gingivitis (HP:0000230) | 2.50761884 |
| 40 | Cellulitis (HP:0100658) | 2.49893549 |
| 41 | Prolonged partial thromboplastin time (HP:0003645) | 2.48649594 |
| 42 | Hyperlipoproteinemia (HP:0010980) | 2.48186496 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 2.47454864 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.45811133 |
| 45 | Polygenic inheritance (HP:0010982) | 2.45763387 |
| 46 | Easy fatigability (HP:0003388) | 2.45417646 |
| 47 | Rhabdomyolysis (HP:0003201) | 2.42412854 |
| 48 | Impaired platelet aggregation (HP:0003540) | 2.41274261 |
| 49 | Abnormal platelet function (HP:0011869) | 2.41274261 |
| 50 | Colitis (HP:0002583) | 2.40514804 |
| 51 | Hypobetalipoproteinemia (HP:0003563) | 2.40333427 |
| 52 | Amyloidosis (HP:0011034) | 2.38742592 |
| 53 | Asymmetric septal hypertrophy (HP:0001670) | 2.38492418 |
| 54 | Myopathic facies (HP:0002058) | 2.36776183 |
| 55 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.36046612 |
| 56 | Complement deficiency (HP:0004431) | 2.35698393 |
| 57 | Cervical subluxation (HP:0003308) | 2.34947707 |
| 58 | Hemorrhage of the eye (HP:0011885) | 2.34558702 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33496424 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33496424 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33496424 |
| 62 | Bulbar palsy (HP:0001283) | 2.33334132 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.32237743 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.31689895 |
| 65 | Myocardial infarction (HP:0001658) | 2.31475792 |
| 66 | Polycythemia (HP:0001901) | 2.31174765 |
| 67 | Symptomatic seizures (HP:0011145) | 2.31144328 |
| 68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.31013515 |
| 69 | Hyperglycinuria (HP:0003108) | 2.29179687 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.25576374 |
| 71 | Increased variability in muscle fiber diameter (HP:0003557) | 2.23954754 |
| 72 | Meningitis (HP:0001287) | 2.23437217 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.21812796 |
| 74 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20324443 |
| 75 | Optic neuritis (HP:0100653) | 2.19669451 |
| 76 | Retrobulbar optic neuritis (HP:0100654) | 2.19669451 |
| 77 | Gingival bleeding (HP:0000225) | 2.19515513 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.19233979 |
| 79 | Distal lower limb amyotrophy (HP:0008944) | 2.17949237 |
| 80 | Hyperbilirubinemia (HP:0002904) | 2.17421929 |
| 81 | Hypoalphalipoproteinemia (HP:0003233) | 2.17299075 |
| 82 | Chest pain (HP:0100749) | 2.16690812 |
| 83 | Hypolipoproteinemia (HP:0010981) | 2.14975527 |
| 84 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.14753197 |
| 85 | Insulin resistance (HP:0000855) | 2.12705576 |
| 86 | Recurrent skin infections (HP:0001581) | 2.10953860 |
| 87 | Loss of speech (HP:0002371) | 2.08991241 |
| 88 | Hyperacusis (HP:0010780) | 2.07602177 |
| 89 | Metaphyseal cupping (HP:0003021) | 2.07114926 |
| 90 | Axonal loss (HP:0003447) | 2.05469559 |
| 91 | Ventricular tachycardia (HP:0004756) | 2.05206864 |
| 92 | Gout (HP:0001997) | 2.05082422 |
| 93 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.05054100 |
| 94 | Abnormality of complement system (HP:0005339) | 2.02916157 |
| 95 | Exercise-induced muscle cramps (HP:0003710) | 2.02797639 |
| 96 | Protrusio acetabuli (HP:0003179) | 2.02737222 |
| 97 | Increased connective tissue (HP:0009025) | 2.02532123 |
| 98 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02430011 |
| 99 | Mucopolysacchariduria (HP:0008155) | 2.02430011 |
| 100 | Nasal polyposis (HP:0100582) | 2.02404831 |
| 101 | Purpura (HP:0000979) | 2.02324578 |
| 102 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02287502 |
| 103 | Epistaxis (HP:0000421) | 2.01934005 |
| 104 | Abnormality of glycine metabolism (HP:0010895) | 2.01520732 |
| 105 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.01520732 |
| 106 | Muscle fiber splitting (HP:0003555) | 2.01071205 |
| 107 | Peritonitis (HP:0002586) | 1.99184913 |
| 108 | Stridor (HP:0010307) | 1.97747015 |
| 109 | Neuronal loss in central nervous system (HP:0002529) | 1.96497345 |
| 110 | Difficulty running (HP:0009046) | 1.96058913 |
| 111 | Joint stiffness (HP:0001387) | 1.95444345 |
| 112 | Pustule (HP:0200039) | 1.95040220 |
| 113 | Abnormality of the thoracic spine (HP:0100711) | 1.94641345 |
| 114 | Increased serum ferritin (HP:0003281) | 1.94631736 |
| 115 | Abnormality of T cell physiology (HP:0011840) | 1.94442998 |
| 116 | Esophageal varix (HP:0002040) | 1.94216892 |
| 117 | Thoracic kyphosis (HP:0002942) | 1.94144937 |
| 118 | Systemic lupus erythematosus (HP:0002725) | 1.93701477 |
| 119 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93132430 |
| 120 | Ulnar deviation of the wrist (HP:0003049) | 1.92807306 |
| 121 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.92530613 |
| 122 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.92493317 |
| 123 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.92493317 |
| 124 | Metabolic acidosis (HP:0001942) | 1.92103446 |
| 125 | Menorrhagia (HP:0000132) | 1.91850978 |
| 126 | Abnormality of nucleobase metabolism (HP:0010932) | 1.91541689 |
| 127 | Increased muscle lipid content (HP:0009058) | 1.91334499 |
| 128 | Hyporeflexia of lower limbs (HP:0002600) | 1.90872228 |
| 129 | Hypercholesterolemia (HP:0003124) | 1.89997626 |
| 130 | IgM deficiency (HP:0002850) | 1.89507806 |
| 131 | Vertebral compression fractures (HP:0002953) | 1.89353230 |
| 132 | Abnormality of iron homeostasis (HP:0011031) | 1.88232735 |
| 133 | Interstitial pulmonary disease (HP:0006530) | 1.86972430 |
| 134 | Vacuolated lymphocytes (HP:0001922) | 1.86332089 |
| 135 | Gastrointestinal inflammation (HP:0004386) | 1.85895802 |
| 136 | Deformed sella turcica (HP:0002681) | 1.85282618 |
| 137 | Eczematoid dermatitis (HP:0000976) | 1.84552362 |
| 138 | Emphysema (HP:0002097) | 1.84154592 |
| 139 | Exercise-induced myalgia (HP:0003738) | 1.83195396 |
| 140 | Hyperglycemia (HP:0003074) | 1.82483707 |
| 141 | Chronic otitis media (HP:0000389) | 1.82080508 |
| 142 | Vasculitis (HP:0002633) | 1.81218817 |
| 143 | Inflammation of the large intestine (HP:0002037) | 1.81097316 |
| 144 | Difficulty climbing stairs (HP:0003551) | 1.81052589 |
| 145 | Malnutrition (HP:0004395) | 1.80994207 |
| 146 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.80977237 |
| 147 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80185135 |
| 148 | Nuclear cataract (HP:0100018) | 1.80017796 |
| 149 | Multiple enchondromatosis (HP:0005701) | 1.79470347 |
| 150 | Prolonged bleeding time (HP:0003010) | 1.79456578 |
| 151 | Hepatic necrosis (HP:0002605) | 1.79099500 |
| 152 | Petechiae (HP:0000967) | 1.78510191 |
| 153 | Mitral regurgitation (HP:0001653) | 1.78182233 |
| 154 | Type 1 muscle fiber predominance (HP:0003803) | 1.77627513 |
| 155 | Growth hormone excess (HP:0000845) | 1.77587178 |
| 156 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.75854299 |
| 157 | Aneurysm (HP:0002617) | 1.75825276 |
| 158 | Lymphangioma (HP:0100764) | 1.75711689 |
| 159 | Restrictive lung disease (HP:0002091) | 1.75566411 |
| 160 | Hematochezia (HP:0002573) | 1.75234053 |
| 161 | Large for gestational age (HP:0001520) | 1.75110922 |
| 162 | Arterial thrombosis (HP:0004420) | 1.75080675 |
| 163 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73713138 |
| 164 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73713138 |
| 165 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73713138 |
| 166 | Hypercortisolism (HP:0001578) | 1.73676238 |
| 167 | Microcytic anemia (HP:0001935) | 1.71440858 |
| 168 | Fat malabsorption (HP:0002630) | 1.70471138 |
| 169 | Pancreatitis (HP:0001733) | 1.70470494 |
| 170 | Hypertriglyceridemia (HP:0002155) | 1.70339775 |
| 171 | Epidermoid cyst (HP:0200040) | 1.70317792 |
| 172 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.69983730 |
| 173 | Autoimmune thrombocytopenia (HP:0001973) | 1.69653127 |
| 174 | Dysostosis multiplex (HP:0000943) | 1.69629240 |
| 175 | Lipoatrophy (HP:0100578) | 1.69587513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.19304822 |
| 2 | PKN2 | 3.38301737 |
| 3 | ERN1 | 3.34377434 |
| 4 | MAP4K1 | 3.02783781 |
| 5 | BCKDK | 3.01373107 |
| 6 | PRPF4B | 2.84400110 |
| 7 | SMG1 | 2.81459289 |
| 8 | NME2 | 2.32960629 |
| 9 | FLT3 | 2.29545514 |
| 10 | RIPK4 | 2.27455501 |
| 11 | EEF2K | 2.12017442 |
| 12 | MAP3K10 | 2.10759602 |
| 13 | TTN | 2.09847973 |
| 14 | TAOK3 | 2.05805204 |
| 15 | FGFR4 | 2.02096153 |
| 16 | TNK2 | 2.01664889 |
| 17 | KDR | 1.87102850 |
| 18 | SIK1 | 1.86550298 |
| 19 | ZAP70 | 1.84120102 |
| 20 | MAP2K3 | 1.83356575 |
| 21 | TYK2 | 1.81288915 |
| 22 | TBK1 | 1.79159655 |
| 23 | PTK6 | 1.75497230 |
| 24 | JAK3 | 1.71988386 |
| 25 | TGFBR2 | 1.63064271 |
| 26 | LRRK2 | 1.57597762 |
| 27 | SIK2 | 1.49097011 |
| 28 | BTK | 1.48563027 |
| 29 | TIE1 | 1.46068662 |
| 30 | MARK2 | 1.45120835 |
| 31 | ICK | 1.44315694 |
| 32 | EPHB1 | 1.40558068 |
| 33 | PASK | 1.38332072 |
| 34 | PRKD2 | 1.33781744 |
| 35 | MAP3K13 | 1.33044094 |
| 36 | SIK3 | 1.32399185 |
| 37 | FES | 1.29938044 |
| 38 | BLK | 1.25862232 |
| 39 | PIK3CG | 1.25486688 |
| 40 | NEK9 | 1.24227620 |
| 41 | CDC42BPA | 1.23948272 |
| 42 | KIT | 1.20873253 |
| 43 | RIPK1 | 1.13184116 |
| 44 | SCYL2 | 1.09478316 |
| 45 | TGFBR1 | 1.07689031 |
| 46 | IRAK3 | 1.07243352 |
| 47 | INSRR | 1.06359383 |
| 48 | RPS6KA4 | 1.04408908 |
| 49 | IKBKE | 1.04078547 |
| 50 | EPHA2 | 1.01920830 |
| 51 | PDPK1 | 1.00692947 |
| 52 | MAP3K6 | 0.99455620 |
| 53 | HIPK2 | 0.98563530 |
| 54 | RPS6KA2 | 0.98487558 |
| 55 | TESK1 | 0.97395977 |
| 56 | JAK1 | 0.96324554 |
| 57 | STK10 | 0.94988242 |
| 58 | TAOK2 | 0.93406009 |
| 59 | IRAK2 | 0.92648835 |
| 60 | ITK | 0.90697041 |
| 61 | MAPK11 | 0.90070189 |
| 62 | MUSK | 0.90029990 |
| 63 | CSF1R | 0.89928462 |
| 64 | MAP3K7 | 0.87622695 |
| 65 | JAK2 | 0.87009786 |
| 66 | GRK6 | 0.86413817 |
| 67 | PIM2 | 0.86006116 |
| 68 | TEC | 0.83246621 |
| 69 | CSK | 0.82008015 |
| 70 | CDK4 | 0.81108272 |
| 71 | CAMKK1 | 0.79893123 |
| 72 | OBSCN | 0.79776073 |
| 73 | MAPKAPK3 | 0.78506012 |
| 74 | MAP3K11 | 0.77968327 |
| 75 | MAP2K2 | 0.76736175 |
| 76 | MAP3K3 | 0.75520678 |
| 77 | TESK2 | 0.75331988 |
| 78 | PAK4 | 0.74491302 |
| 79 | RPS6KB2 | 0.72502034 |
| 80 | IRAK4 | 0.72446146 |
| 81 | NLK | 0.72000521 |
| 82 | IKBKB | 0.71080290 |
| 83 | KSR2 | 0.71040957 |
| 84 | ILK | 0.70611153 |
| 85 | SYK | 0.69898880 |
| 86 | MAPK7 | 0.68529227 |
| 87 | LMTK2 | 0.67051173 |
| 88 | DYRK1B | 0.66559827 |
| 89 | TYRO3 | 0.66453128 |
| 90 | EPHA3 | 0.66139422 |
| 91 | CAMK1D | 0.65669330 |
| 92 | LCK | 0.65487692 |
| 93 | PRKD3 | 0.65302619 |
| 94 | RET | 0.64038261 |
| 95 | CDK12 | 0.62191109 |
| 96 | BMX | 0.61746124 |
| 97 | DMPK | 0.61215656 |
| 98 | FGFR3 | 0.60136104 |
| 99 | PIM1 | 0.60051717 |
| 100 | FGR | 0.59921631 |
| 101 | NEK2 | 0.59300024 |
| 102 | CDK6 | 0.57134361 |
| 103 | MAPK15 | 0.56695423 |
| 104 | PRKG2 | 0.56665881 |
| 105 | MAP3K8 | 0.56546481 |
| 106 | HCK | 0.55785849 |
| 107 | MAP3K14 | 0.53517272 |
| 108 | PRKAA2 | 0.52797909 |
| 109 | MTOR | 0.52078283 |
| 110 | STK38 | 0.52038445 |
| 111 | MAP2K6 | 0.50639864 |
| 112 | CHUK | 0.49726157 |
| 113 | PDGFRA | 0.48693251 |
| 114 | MAP3K1 | 0.48052962 |
| 115 | MYLK | 0.47753685 |
| 116 | IRAK1 | 0.47134692 |
| 117 | PAK2 | 0.44970977 |
| 118 | MST1R | 0.44243460 |
| 119 | STK4 | 0.43969565 |
| 120 | ARAF | 0.43856219 |
| 121 | MAPKAPK2 | 0.43703847 |
| 122 | TXK | 0.43214743 |
| 123 | MARK3 | 0.41740286 |
| 124 | RPS6KA6 | 0.40068738 |
| 125 | FYN | 0.39601094 |
| 126 | LYN | 0.39591983 |
| 127 | PRKD1 | 0.39308150 |
| 128 | MAPK12 | 0.37970957 |
| 129 | MAPK4 | 0.37229634 |
| 130 | SGK3 | 0.37222153 |
| 131 | RPS6KA1 | 0.34885147 |
| 132 | RPS6KL1 | 0.33941893 |
| 133 | RPS6KC1 | 0.33941893 |
| 134 | PTK2 | 0.33767678 |
| 135 | PDK1 | 0.33363940 |
| 136 | CAMK1G | 0.32727808 |
| 137 | TAOK1 | 0.31025060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.72339553 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.50404344 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.43417362 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.40684472 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.37809330 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37327642 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.27985437 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.21499782 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.08672298 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04254026 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02167873 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.92831051 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.90504973 |
| 14 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.86740693 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.84376929 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.75025820 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.72169637 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.69597551 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.67649324 |
| 20 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.66850271 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.65097158 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60356114 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58621125 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.57373267 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54150805 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53873749 |
| 27 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.53509555 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52628208 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51303394 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.48362956 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45152347 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42623203 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41331884 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40479933 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.39001205 |
| 36 | Lysine degradation_Homo sapiens_hsa00310 | 1.33003506 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.31372926 |
| 38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31021444 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.28368074 |
| 40 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.27146429 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26976022 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.24564225 |
| 43 | Endometrial cancer_Homo sapiens_hsa05213 | 1.23715536 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22604645 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21423274 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21267980 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.21056576 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17603653 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16216122 |
| 50 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15895467 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14210192 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.13846052 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12796615 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12794552 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11596865 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11043279 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10763509 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09823869 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08948417 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08470914 |
| 61 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.07981020 |
| 62 | Influenza A_Homo sapiens_hsa05164 | 1.07715479 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07605353 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 1.07428133 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.07337302 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05307538 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03351071 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.02768986 |
| 69 | Malaria_Homo sapiens_hsa05144 | 1.02085297 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 1.01946391 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99809214 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.99083037 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99001542 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97361129 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97302563 |
| 76 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96806835 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96460212 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94303188 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.93540085 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.93314107 |
| 81 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93107955 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.92649656 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.92369527 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.92247303 |
| 85 | DNA replication_Homo sapiens_hsa03030 | 0.91572161 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.91090888 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90993866 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.90343601 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89806886 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89691938 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89502403 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89386073 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.89298004 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89269791 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89154666 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89052777 |
| 97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.88316331 |
| 98 | Protein export_Homo sapiens_hsa03060 | 0.88114068 |
| 99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86277558 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85920692 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84910852 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83651220 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83329675 |
| 104 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82324400 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80361647 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.76836008 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76072957 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75865208 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.75774827 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.75677898 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75636424 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75136697 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.74538893 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74476957 |
| 115 | Phagosome_Homo sapiens_hsa04145 | 0.73487302 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72800386 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72041560 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.71403491 |
| 119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71180066 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70716379 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70642563 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.68574118 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68111855 |
| 124 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67851544 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66989399 |
| 126 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66583710 |
| 127 | Leishmaniasis_Homo sapiens_hsa05140 | 0.64955508 |
| 128 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64472218 |
| 129 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.63282862 |
| 130 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62413511 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62085526 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60896788 |
| 133 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60370250 |
| 134 | Shigellosis_Homo sapiens_hsa05131 | 0.60171616 |
| 135 | Focal adhesion_Homo sapiens_hsa04510 | 0.59739648 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59583208 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58751628 |
| 138 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58676648 |
| 139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58225088 |
| 140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54974331 |
| 141 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54918573 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54291455 |
| 143 | Measles_Homo sapiens_hsa05162 | 0.53040468 |
| 144 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52195005 |
| 145 | Legionellosis_Homo sapiens_hsa05134 | 0.48413803 |
| 146 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.48041646 |
| 147 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47414378 |
| 148 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47110854 |
| 149 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46117219 |
| 150 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45518052 |
| 151 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.44992271 |
| 152 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44945443 |
| 153 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44802832 |
| 154 | Lysosome_Homo sapiens_hsa04142 | 0.42929307 |
| 155 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42592459 |
| 156 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42552688 |
| 157 | Mismatch repair_Homo sapiens_hsa03430 | 0.42402458 |
| 158 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40942032 |
| 159 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40078084 |
| 160 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40034044 |
| 161 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39325761 |
| 162 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38919227 |
| 163 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.38437684 |
| 164 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38269437 |
| 165 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38125632 |
| 166 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36459523 |
| 167 | Base excision repair_Homo sapiens_hsa03410 | 0.36352304 |
| 168 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.32968027 |

